Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Zink

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Der Nervenarzt|July 5, 2022
[Obsessive-compulsive symptoms in psychotic disorders: pathogenesis and treatment]Frederike Schirmbeck, Mathias Zink
Neuroreport|February 25, 2005
Ethanol induces GAD67 and VGAT in slice cultures of newborn rat cerebral cortexMathias Zink, Rainer Spanagel
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 15, 2008
Combined antipsychotic treatment involving clozapine and aripiprazoleSusanne Englisch, Mathias Zink
Current Neuropharmacology|September 4, 2012
Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical reviewFrederike Schirmbeck, Mathias Zink
Expert Review of Clinical Pharmacology|April 29, 2015
Glutamatergic agents for schizophrenia: current evidence and perspectivesMathias Zink, Christoph U Correll
The Australian and New Zealand Journal of Psychiatry|April 28, 2007
Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophreniaMathias Zink, Udo Knopf, Anna Kuwilsky
Journal of Clinical Psychopharmacology|April 7, 2007
Olanzapine-associated bilateral eyelid edemaMathias Zink, Anna Kuwilsky, Udo Knopf
Psychopathology|July 3, 2008
Neurobiology confirms psychopathology. On the antagonism of psychosis and obsessive-compulsive syndromesMathias Zink, Susanne Englisch, Harald Dressing
European Archives of Psychiatry and Clinical Neuroscience|September 13, 2014
Antipsychotic treatment modulates glutamate transport and NMDA receptor expressionMathias Zink, Susanne Englisch, Andrea Schmitt
Psychiatrische Praxis|March 5, 2024
[The (near) Future of Psychiatric Hospitals in Germany]Hermann Spießl, Mathias Zink, Peter Zwanzger
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Der Nervenarzt|July 5, 2022
[Obsessive-compulsive symptoms in psychotic disorders: pathogenesis and treatment]Frederike Schirmbeck, Mathias Zink
Neuroreport|February 25, 2005
Ethanol induces GAD67 and VGAT in slice cultures of newborn rat cerebral cortexMathias Zink, Rainer Spanagel
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 15, 2008
Combined antipsychotic treatment involving clozapine and aripiprazoleSusanne Englisch, Mathias Zink
Current Neuropharmacology|September 4, 2012
Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical reviewFrederike Schirmbeck, Mathias Zink
Expert Review of Clinical Pharmacology|April 29, 2015
Glutamatergic agents for schizophrenia: current evidence and perspectivesMathias Zink, Christoph U Correll
The Australian and New Zealand Journal of Psychiatry|April 28, 2007
Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophreniaMathias Zink, Udo Knopf, Anna Kuwilsky
Journal of Clinical Psychopharmacology|April 7, 2007
Olanzapine-associated bilateral eyelid edemaMathias Zink, Anna Kuwilsky, Udo Knopf
Psychopathology|July 3, 2008
Neurobiology confirms psychopathology. On the antagonism of psychosis and obsessive-compulsive syndromesMathias Zink, Susanne Englisch, Harald Dressing
European Archives of Psychiatry and Clinical Neuroscience|September 13, 2014
Antipsychotic treatment modulates glutamate transport and NMDA receptor expressionMathias Zink, Susanne Englisch, Andrea Schmitt
Psychiatrische Praxis|March 5, 2024
[The (near) Future of Psychiatric Hospitals in Germany]Hermann Spießl, Mathias Zink, Peter Zwanzger
Pageof 12